Non-small Cell Lung Cancer Stage IV Clinical Trials
30 clinical trials for Non-small Cell Lung Cancer Stage IV across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer — RECRUITING · PHASE1
- Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer — RECRUITING · PHASE2
- Pulmonary Rehabilitation in Advanced Lung Cancer Survivors — RECRUITING · PHASE2
- Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer — RECRUITING · PHASE2
- [177Lu]Lu-AKIR001 First-in-human Study — RECRUITING · PHASE1
- Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer — RECRUITING
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013) — TERMINATED · PHASE2
- A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer — ACTIVE_NOT_RECRUITING · PHASE3
- A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer — TERMINATED · PHASE1
- Immunotherapy in Patient With Poor General Condition — COMPLETED · PHASE2
- Intrathecal Double Checkpoint Inhibition — ACTIVE_NOT_RECRUITING · PHASE1
- Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC — COMPLETED · PHASE2
- Xingbai Ji Formula Combined with Chemotherapy and Sintilimab in Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer: a Clinical Trial — NOT_YET_RECRUITING · NA
- Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis — COMPLETED · PHASE2
- Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet) — OTHER · NA
- Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCLC — NOT_YET_RECRUITING · PHASE2
- Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC — COMPLETED · PHASE2
- The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC — NOT_YET_RECRUITING
- Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition — TERMINATED · PHASE1
- Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC — OTHER · PHASE2
- A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer — COMPLETED · PHASE2
- Tumor Mutational Burden in Lung Cancer Patients — TERMINATED
- Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) — OTHER
- Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC — COMPLETED · PHASE2
- Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial — COMPLETED · PHASE2
- Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer — COMPLETED · PHASE3
- A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC — TERMINATED · PHASE3
- Phase II Avastin Trial for Stage IIIB/IV NSCLC — TERMINATED · PHASE2
- Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer — TERMINATED · PHASE2
- SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer — COMPLETED · PHASE2
Refine this search